This session will present findings from the Phase 2a PORTOLA trial evaluating zetomipzomib, a first-in-class selective immunoproteasome inhibitor, in autoimmune hepatitis. Attendees will hear insights on the study design and clinical outcomes, followed by expert discussion on the potential role of immunoproteasome inhibition in advancing treatment for this challenging disease.<br />
<br />
Industry Supporter:&nbsp;Kezar Life Sciences, Inc

Learn more about a treatment option for your patients with progressive familial intrahepatic cholestasis (PFIC) or Alagille syndrome (ALGS). Join us as Dr. Sheflin-Findling discusses an overview of PFIC and ALGS and a deep-dive into an approved treatment option for your pediatric, adolescent, and adult patients.<br />
<br />
Industry Supporter:&nbsp;Ipsen Biopharmaceuticals

Join us for a symposium on alpha-1 antitrypsin deficiency (AATD) designed to encourage the exchange of ideas between leaders in the field and attendees.<br />
<br />
<br />
Supported by: Takeda<br />
<br />
Organized by: Medscape Education<br />
<br />
<br />
For more information and to register, visit:&nbsp;<a href="https://events.medscapelive.org/website/88422/">https://www.medscape.or… />
<br />
Important Note: Continuing education credits for Satellite Symposia are offered by the sponsoring organizations. These sessions are not accredited by AASLD.

In this engaging session, patient advocates will share their personal experiences living with liver disease, from the moment of diagnosis through treatment and daily management. Their stories will shed light on the emotional and medical challenges faced along the way. A physician will join the panel to provide clinical insights and participate in a thoughtful discussion on enhancing patient-centered care and communication.<br />
<br />
<strong>Zoom: </strong><a href="https://liverfoundation.org/events/beyond-the-diagnosis-patient-journey…;

The following poster categories will be in the Poster Hall:
<ul>
<li>Acute Liver Failure and Artificial Liver Support</li>
<li>Acute on Chronic Liver Failure</li>
<li>Biliary Physiology, Transport, Cholangiocyte Biology, and Experimental Cholestasis</li>
<li>Cell and Molecular Biology</li>
<li>Genomics and Precision Medicine</li>
<li>Gut Liver Axis and Microbiome</li>
<li>Hepatotoxicity</li>
<li>Human Cholestatic and Autoimmune Liver Diseases</li>
<li>Inflammation and Immunobiology</li>
<li>Pediatric Hepatology</li>
<li>Vascular Liver Disease, Hemostasis and Thrombosis</li>
<li>MASLD/MASH -Therapeutics: Approved/available agents</li>
<li>Therapeutics: New Agents - MASLD and MASH</li>
</ul>

Join us for a poster highlight of the top abstracts from the Liver Cancer SIG.&nbsp;<br />
&nbsp;

The transplant journey is a complex and emotional process that differs across age groups while sharing critical milestones. Experts explore the unique challenges and experiences of pediatric and adult transplant patients from initial diagnosis to long-term survivorship. Through the lens of the transplant journey map, speakers connect real-life experiences to key stages in the transplant process, providing insights for patients, families, and care teams to navigate this life-changing path.

Join the Friends of the PBC Foundation, NFP in a patient-led discussion on the unmet needs of the U.S. PBC patient community and how to better address them in 2026 and beyond.<br />
<br />
Zoom link for the PBC Community Conversation<strong>:</strong>&nbsp;<a href="http://https://us06web.zoom.us/j/82651012192?pwd=493L6C56dZGd1hTQBRMibb…;

Join a panel of patients, caregivers, and patient advocacy leaders who participated in the National Liver Gathering, a first-of-its-kind scientific conference that places patients at the center of research, clinical practice, and policy discussions.<br />
<br />
This session will share key insights from across disease areas, including MASH, viral hepatitis elimination, harm reduction, rare liver diseases, liver cancer, transplantation, and pediatric liver disease &mdash; and reflect on how patient voices shaped the conversations.<br />
<br />
Attendees will learn how this model fosters collaboration between the scientific and patient communities and will have an opportunity to discuss how to expand this patient-centered approach nationally.<br />
<br />
<strong>Zoom:</strong> <a href="https://us02web.zoom.us/j/84067329881?pwd=jRzdmOz9cUQLP7tT4Y6Ce5HcpCRLd…;

Join us for a poster highlight of the top abstracts from the Hepatitis B/Delta (HBV/HDV) SIG.&nbsp;<br />
&nbsp;